A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: Study protocol for a randomized controlled trial

Kaarin J. Anstey, Alex Bahar-Fuchs, Pushpani Herath, George W. Rebok, Nicolas Cherbuin

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: Study protocol for a randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences